Tanaka Atsushi, Takemoto Masao, Masumoto Akihiro, Kang Honsa, Mito Takahiro, Kumeda Hiroshi, Aoki Ryota, Kinoshita Satoko, Antoku Yoshibumi, Matsuo Atsutoshi, Hida Satoru, Okazaki Teiji, Tayama Kei-Ichiro, Kosuga Ken-Ichi
Cardiovascular Center Munakata Suikokai General Hospital Fukutsu Japan.
Cardiology Fukuoka Kinen Hospital Fukuoka Japan.
J Arrhythm. 2019 Feb 15;35(2):252-261. doi: 10.1002/joa3.12167. eCollection 2019 Apr.
This study aimed to investigate the effects of radiofrequency catheter ablation (RFCA) and clinical and electrophysiological characteristics in symptomatic patients with premature ventricular contractions (PVCs) from near the His-bundle (His-PVCs).
The patient characteristics, prevalence of complications with any life style related disease (ALSRD) including hypertension, dyslipidemia, or diabetes mellitus, and/or cardiovascular disease (CVD) including coronary artery disease, cerebrovascular disease, renal dysfunction, or cardiomyopathy, clinical status, frequency of PVCs evaluated by 24hour Holter monitoring, echocardiography including the left ventricular diastolic dysfunction (LVDD) parameters, and electrophysiological findings were evaluated in 14 consecutive symptomatic patients with His-PVCs.
The prevalence of males, being elderly and/or slightly obese, current and/or history of smoking, ALSRD or CVD related complications, and LVDD probably resulting from ALSRD and/or CVD complications were higher in patients with His-PVCs. RFCA of His-PVCs steadily decreased the PVC frequency and improved the systolic function, LV dilation, and clinical status, but not the LVDD. There was a significant relationship between the accordance rate of the QRS polarity between sinus rhythm and His-PVCs and the distance between the successful ablation site and His-bundle.
The analysis of the QRS duration and accordance rate of the QRS polarity between sinus rhythm and His-PVCs before the RFCA may help to determine the distance between the origin of the PVCs and His-bundle. Further, the appropriate ablation catheter may be selected during the RFCA procedure. Finally, RFCA may be one of the most effective, feasible, and safest therapies for symptomatic patients with His-PVCs.
本研究旨在探讨射频导管消融术(RFCA)对希氏束旁室性早搏(His-PVCs)有症状患者的影响以及临床和电生理特征。
对14例连续的有症状His-PVCs患者的患者特征、包括高血压、血脂异常或糖尿病在内的任何与生活方式相关疾病(ALSRD)和/或包括冠状动脉疾病、脑血管疾病、肾功能不全或心肌病在内的心血管疾病(CVD)的并发症患病率、临床状况、通过24小时动态心电图监测评估的室性早搏频率、包括左心室舒张功能障碍(LVDD)参数在内的超声心动图以及电生理检查结果进行了评估。
His-PVCs患者中男性、老年和/或轻度肥胖、当前和/或既往吸烟史、ALSRD或CVD相关并发症以及可能由ALSRD和/或CVD并发症导致的LVDD的患病率较高。His-PVCs的RFCA使室性早搏频率稳步下降,并改善了收缩功能、左心室扩张和临床状况,但未改善LVDD。窦性心律与His-PVCs之间QRS极性的符合率与成功消融部位与希氏束之间的距离存在显著关系。
RFCA术前对QRS时限以及窦性心律与His-PVCs之间QRS极性符合率的分析可能有助于确定室性早搏起源与希氏束之间的距离。此外,在RFCA手术过程中可选择合适的消融导管。最后,RFCA可能是有症状His-PVCs患者最有效、可行和安全的治疗方法之一。